Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Izhar S Batth

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|June 3, 2020
Discovery of Cell-Surface Vimentin (CSV) as a Sarcoma Target and Development of CSV-Targeted IL12 Immune TherapyIzhar S Batth, Shulin Li
Oncoimmunology|January 27, 2017
Regulation of NKG2D<sup>+</sup>CD8<sup>+</sup> T-cell-mediated antitumor immune surveillance: Identification of a novel CD28 activation-mediated, STAT3 phosphorylation-dependent mechanismJiemiao Hu, Izhar S Batth, Xueqing Xia, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 27, 2019
CTC analysis: an update on technological progressIzhar S Batth, Abhisek Mitra, Sierra Rood, et al.
BMC Cancer|August 2, 2020
Rare osteosarcoma cell subpopulation protein array and profiling using imaging mass cytometry and bioinformatics analysisIzhar S Batth, Qing Meng, Qi Wang, et al.
Oncoimmunology|May 4, 2018
Cell-surface vimentin-positive macrophage-like circulating tumor cells as a novel biomarker of metastatic gastrointestinal stromal tumorsHeming Li, Qing H Meng, Hyangsoon Noh, et al.
International Journal of Cancer|June 8, 2020
Cell surface vimentin-positive circulating tumor cell-based relapse prediction in a long-term longitudinal study of postremission neuroblastoma patientsIzhar S Batth, Long Dao, Arun Satelli, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|June 3, 2020
Discovery of Cell-Surface Vimentin (CSV) as a Sarcoma Target and Development of CSV-Targeted IL12 Immune TherapyIzhar S Batth, Shulin Li
Oncoimmunology|January 27, 2017
Regulation of NKG2D<sup>+</sup>CD8<sup>+</sup> T-cell-mediated antitumor immune surveillance: Identification of a novel CD28 activation-mediated, STAT3 phosphorylation-dependent mechanismJiemiao Hu, Izhar S Batth, Xueqing Xia, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 27, 2019
CTC analysis: an update on technological progressIzhar S Batth, Abhisek Mitra, Sierra Rood, et al.
BMC Cancer|August 2, 2020
Rare osteosarcoma cell subpopulation protein array and profiling using imaging mass cytometry and bioinformatics analysisIzhar S Batth, Qing Meng, Qi Wang, et al.
Oncoimmunology|May 4, 2018
Cell-surface vimentin-positive macrophage-like circulating tumor cells as a novel biomarker of metastatic gastrointestinal stromal tumorsHeming Li, Qing H Meng, Hyangsoon Noh, et al.
International Journal of Cancer|June 8, 2020
Cell surface vimentin-positive circulating tumor cell-based relapse prediction in a long-term longitudinal study of postremission neuroblastoma patientsIzhar S Batth, Long Dao, Arun Satelli, et al.
Pageof 1